Found a bug or want a feature? Verified reports earn free credits.
Log inSign up
Companies›Healthcare›Healthcare›Pharmaceuticals & Biotechnology
NSE:BIOFILCHEM

BIOFIL CHEM & PHARMA LTD

Healthcare › Pharmaceuticals & Biotechnology
₹29.23
at close · 28 Oct 2026
▼ 0.16 (-0.54%)

Latest filings

  1. Routine quarterly RTA certificate for securities dematerialization Q2 FY26 · Compliance
  2. Trading Window Closure from Oct 1, 2026 for Q2 Results · Compliance
  3. Shareholder nod to continue 75+ Independent Director · Management Changes
All filings ↓
Ask Nexa about BIOFIL CHEM & PHARMA LTD

Snapshot

What the business is, and whether it's a good one at a fair price.

A Pharmaceuticals & Biotechnology company listed on NSE and BSE, reporting revenue of ₹34 Cr over the trailing twelve months.

Market Cap
₹48 Cr
P / E (TTM)
97.4×
EV / EBITDA
46.0×
Div Yield
—
Growth
-4.5%▼
Revenue 5y CAGR
PAT +17.5% · EBITDA +9.2%
Quality
4.9%·
ROCE (5y median)
ROE 3.9% (5y median) · margin 13.1%
Leverage
0.14·
Debt / Equity · low
Net debt ₹2.96 Cr
Revenue FY21→FY26
0.8×▼
Margin +6.3 pts
₹36 Cr → ₹28 Cr
Cash conversion
-0.09×▼
Operating cash ÷ profit · 5 yrs
₹-0 Cr on ₹5 Cr
Moves on a normal day
1.27%·
Median daily move
Last 267 sessions · the yardstick for filing-day moves
Where it sits among 185 Pharmaceuticals peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#140/158
P/B#62/163
ROCE#59/183
ROE#57/166
Debt / Equity#81/166
EBITDA margin#152/165
Revenue growth#11/161
Profit growth#145/158

Scorecard

Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice

Strengths
Profit compounding 18% a year over 5 years
Concerns
Revenue shrinking over 5 years (−5% a year)
Erratic profits — up in only 2 of the last 5 years
Returns on capital 4.9% (5-year median)
#59 of 183 in Pharmaceuticals on the latest reported figures · up from 12.1% in FY21
Over 5 years it reported ₹5.31 Cr of profit and an operating cash outflow of ₹0.47 Cr — -0.09×
Less than 60p of every ₹1 of profit arrived as cash
Heavy working capital — 187 days of cash tied up
Customers are taking longer to pay — 176 → 355 days of receivables
FY21 → FY26

Charts

How has the market priced it — with filings on the timeline?

BIOFILCHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from BIOFIL CHEM & PHARMA LTD's filed financials and exchange disclosures

What does BIOFIL CHEM & PHARMA LTD do?

BIOFIL CHEM & PHARMA LTD is a Pharmaceuticals & Biotechnology company listed on NSE and BSE, trading under the symbol BIOFILCHEM.

Is BIOFIL CHEM & PHARMA LTD profitable?

Yes. Over the trailing twelve months BIOFIL CHEM & PHARMA LTD reported a net profit of ₹0.48 Cr on revenue of ₹34 Cr.

Does BIOFIL CHEM & PHARMA LTD pay a dividend?

Not in the latest reported year — BIOFIL CHEM & PHARMA LTD's dividend payout for FY26 was nil.

Is BIOFIL CHEM & PHARMA LTD debt-free?

No. It reported borrowings of ₹3.02 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹2.96 Cr after cash. Debt stands at 0.14× equity. That is lower than 52% of its 166 Pharmaceuticals peers.

Is BIOFIL CHEM & PHARMA LTD expensive compared with its peers?

On trailing P/E, BIOFIL CHEM & PHARMA LTD ranks 140 of 158 in Pharmaceuticals — cheaper than 12% of them, against an industry median of 30.8×. This is a position, not a valuation judgement.

How much does the BIOFIL CHEM & PHARMA LTD share price move in a day?

On a typical session BIOFIL CHEM & PHARMA LTD moves 1.27% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.

Where can I track BIOFIL CHEM & PHARMA LTD's announcements?

Every NSE and BSE filing by BIOFIL CHEM & PHARMA LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.